tiprankstipranks
Poseida Therapeutics Strikes Major CAR-T Therapy Collaboration Deal
PremiumCompany AnnouncementsPoseida Therapeutics Strikes Major CAR-T Therapy Collaboration Deal
3M ago
Poseida Therapeutics and Astellas Pharma to develop allogeneic cell therapies
PremiumThe Fly
Poseida Therapeutics and Astellas Pharma to develop allogeneic cell therapies
3M ago
Poseida Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Poseida Therapeutics management to meet with Piper Sandler
3M ago
Poseida: Phase 1 data supports potential of P-BCMA-ALLO1 therapy in MM
PremiumThe FlyPoseida: Phase 1 data supports potential of P-BCMA-ALLO1 therapy in MM
3M ago
Poseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer
PremiumThe Fly
Poseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer
4M ago
Poseida Therapeutics granted FDA orphan designation for P-BCMA-ALLO1
PremiumThe Fly
Poseida Therapeutics granted FDA orphan designation for P-BCMA-ALLO1
4M ago
Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
PremiumPress ReleasesPoseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
5M ago
PSTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PSTX Earnings this Week: How Will it Perform?
5M ago
Poseida Therapeutics price target raised to $10 from $8 at Piper Sandler
PremiumThe Fly
Poseida Therapeutics price target raised to $10 from $8 at Piper Sandler
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100